Welcome and Introductions
Silent Threat, High Stake. What does the latest RWE say about the CMV silent progression and potential consequences?
From evidence to everyday practice. What and when Management & Treatment Choices should be made to improve Outcomes?
A multidisciplinary approach. How should new standards of practice be implemented in collaboration between transplantologist, infectious disease and rest of care team?
Q&A and closing
Panel Round Table Discussion at the ESCMID Global
-”Silent progression, serious consequences. Rethinking CMV post-transplant care with latest scientific real-world evidence”
Seien Sie dabei, wenn führende Expert:innen ihre Erfahrungen und Perspektiven zum CMV-Management teilen und diskutieren.